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Abstract
Whole-cell computational models aim to predict cellular phenotypes from genotype by representing
the entire genome, the structure and concentration of each molecular species, each molecular in-
teraction, and the extracellular environment. Whole-cell models have great potential to transform
bioscience, bioengineering, and medicine. However, numerous challenges remain to achieve whole-
cell models. Nevertheless, researchers are beginning to leverage recent progress in measurement
technology, bioinformatics, data sharing, rule-based modeling, and multi-algorithmic simulation to
build the first whole-cell models. We anticipate that ongoing efforts to develop scalable whole-cell
modeling tools will enable dramatically more comprehensive and more accurate models, including
models of human cells.
Introduction
Whole-cell (WC) computational models aim to predict cellular phenotypes from genotype and the
environment by representing the function of each gene, gene product, and metabolite [1]. WC
models could unify our understanding of cell biology and enable researchers to perform in silico
experiments with complete control, scope, and resolution [2, 3]. WC models could also help bio-
engineers rationally design microorganisms that can produce useful chemicals and act as biosensors,
and help physicians design personalized therapies tailored to each patient’s genome.
Despite their potential, there is little consensus on how WC models should represent cells, what
phenotypes WC models should predict, or how to achieve WC models. Nevertheless, we and others
are beginning to leverage advances in measurement technology, bioinformatics, rule-based modeling,
and multi-algorithmic simulation to develop WC models [4–9]. However, substantial work remains
to achieve WC models [10, 11].
To build consensus on WC modeling, we propose a set of key physical and chemical mechanisms
that WC models should aim to represent, and a set of key phenotypes that WC models should
aim to predict. We also summarize the experimental and computational progress that is making
WC modeling feasible, and outline several technological advances that would help accelerate WC
modeling.
Note, our proposals focus on defining WC models that are needed for research studies and ap-
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plications such as bioengineering and personalized medicine which depend on understanding the
molecular details of the majority of intracellular processes. However, research that depends on
fewer intracellular processes could be served by smaller, more focused models.
Physics and chemistry that WC models should aim to represent
We propose that WC models aim to represent all of the chemical reactions in a cell and all of the
physical processes that influence their rates (Figure 1a). This requires representing (a) the sequence
of each chromosome, RNA, and protein; the location of each chromosomal feature, including each
gene, operon, promoter, and terminator; and the location of each site on each RNA and protein;
(b) the structure of each molecule, including atom-level information about small molecules, the
domains and sites of macromolecules, and the subunit composition of complexes; (c) the subcellular
organization of cells into organelles and microdomains; (d) the participants and effect of each
molecular interaction, including the molecules that are consumed, produced, and transported,
the molecular sites that are modified, and the bonds that are broken and formed, (e) the kinetic
parameters of each interaction; (f) the concentration of each species in each organelle and
microdomain; and (g) the concentration of each species in the extracellular environment. In
addition, to enable WC models to be rigorously tested, each WC model should represent a single,
well-defined experimental system. To minimize the complexity of WC models, we recommend
modeling small, fast-growing, non-adherent, autonomous, self-renewing cells growing on defined,
rich, homogeneous media. Together, this would enable WC models to describe how cellular behavior
emerges from the combined function of each gene and genetic variant, and capture how cells respond
to changes in their internal and external environments.
a b10110011   0011
01100101   01100001
01001001   11001111   101
 00100110   10001000   00010110   
10011000   11010001   01010101   001  
01110001   11110000   10000001   010111  
00110001   10001111   10110100   0111001   
10110011   11111111   01101001   0011010   
01010000   10001100   00100100   11010   
01100011    00011101   11010001   110   
00100101   10001100   10010101   
11001010   10101010   00110   
10010011   1100101  
Stochastic
variation
Spatial
dynamics
Temporal
dynamics
Population
heterogeneity
Complex
phenotypes
Whole-cell model
Physical and chemical representation Predicted phenotypes
Genome Concentrations
Molecular
interactions
Kinetics
Molecular
structures
Environment
Subcellular
organization
ACTGCTGA
TCACCGTA
Figure 1. The physical and chemical mechanisms that WC models should aim to represent (a) and the phenotypes
that WC models should aim to predict (b).
Phenotypes that WC models should aim to predict
We also propose that WC models aim to predict the behavioral trajectories of single cells over
their life cycles, with each simulation representing a different cell within a heterogeneous clonal
population (Figure 1b). This should include behaviors within individual cells such as the stochas-
tic dynamics of each molecular interaction; the temporal dynamics of the concentration of
each species; the spatial dynamics of the concentration of each species in each organelle and
microdomain; and complex phenotypes such as cell shape, growth rate, motility, and fate, as
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well as the variation in the behavior of single cells within clonal populations. Together, this would
enable WC models to capture how stochastic and single-cell variation can generate phenotypic di-
versity; how a cell responds to external cues such as nutrients, growth factors and drugs; and how
a cell coordinates critical events such as the G1/S transition. This would also enable WC models
to generate predictions that could be embedded into higher-order multiscale models. For example,
WC models could predict the timing and speed of chemotaxis, which could help multiscale models
predict tumor metastasis.
Available resources
Achieving WC models will require extensive data to constrain every parameter. Fortunately, mea-
surement technology is rapidly advancing. Here, we review the latest methods for generating data
for WC models, and highlight repositories and other resources that contain useful data for WC
modeling.
Measurement methods
Advances in single-cell and genomic measurement are rapidly generating data that could be used for
WC modeling [12–14] (Table S1). For example, Meth-Seq can assess epigenetic modifications [15],
Hi-C can determine chromosome structures [16], ChIP-seq can determine protein-DNA interactions
[17], fluorescence microscopy can determine protein localizations, mass-spectrometry can quantitate
metabolite and protein concentrations, FISH [18] and scRNA-seq [19] can quantitate the dynam-
ics and single-cell variation of RNA abundances, and fluorescence microscopy and mass cytometry
[20] can quantitate the dynamics and single-cell variation of protein abundances. In particular,
WC models can be constrained by combining high-dimensional measurement methods with mul-
tiple genetic and environmental perturbations, frequent temporal observations, and cutting-edge
distributed parameter estimation methods. However, substantial work remains to develop methods
that can measure non-model organisms including small, slow-growing, and unculturable cells.
Data repositories
Researchers are also rapidly aggregating much of the data needed for WC modeling into public
repositories (Table S2). For example, UniProt contains a multitude of information about proteins
[21]; BioCyc contain extensive information about interactions [22]; ECMDB [23], ArrayExpress [24],
and PaxDb [25] contain metabolite, RNA, and protein abundances, respectively; and SABIO-RK
contains kinetic parameters [26]. Furthermore, meta-databases such as Nucleic Acid Research’s
Database Summary contain lists of repositories [27].
Prediction tools
For certain types of data, accurate prediction tools can be superior to direct experimental evidence
which may have incomplete coverage or may be limited to a small number of genotypes and envi-
ronments. Currently, many tools can predict properties such as operons, RNA folds, and protein
localizations (Table S3). For example, PSORTb predicts the localization of bacterial proteins [28].
However, many current prediction tools lack sufficient accuracy for WC modeling.
Published models
WC models can also incorporate separately published models of individual pathways. Currently,
there are several model repositories which contain numerous cell cycle, circadian rhythm, electrical
signaling, signal transduction, and metabolism models (Table S4–S5). However, most pathways
such as RNA degradation do not yet have genome-scale dynamical models, many reported models
are not publicly available, and it is difficult to merge most published models because they often use
different assumptions and representations.
3
Emerging methods and tools
Recent advances in data aggregation, model design, model representation, and simulation (Table S6)
are also rapidly making WC modeling feasible. We expect that ongoing efforts to adapt and combine
these advances will accelerate WC modeling [9] (Figure 2). Here, we summarize the most important
emerging methods and tools for WC modeling.
10110011   0011
01100101   01100001
01001001   11001111   101
 00100110   10001000   00010110   
10011000   11010001   01010101   001  
01110001   11110000   10000001   010111  
00110001   10001111   10110100   0111001   
10110011   11111111   01101001   0011010   
01010000   10001100   00100100   11010   
01100011    00011101   11010001   110   
00100101   10001100   10010101   
11001010   10101010   00110   
10010011   1100101  
Experimental
data Pathway/genome database Whole-cell model Simulation results Visualization and analysis
a
Data
aggregation
e Validation
b
Model
design
c
Multi-algorithm
simulation
d
Data
reduction
Figure 2. Emerging WC modeling methodology. (a) Data should be aggregated from thousands of publications,
repositories, and prediction tools and organized into a PGDB. (b) Models should be designed, calibrated, and validated
from PGDBs and described using rules. (c) Models should be simulated using parallel, network-free, multi-algorithmic
simulators and their results should be stored in a database. (d) Simulation results should be visualized and analyzed.
(e) Results should be validated by comparison to experimental measurements. Importantly, all of these steps should
be collaborative.
Data aggregation and organization
For optimal accuracy and scope, WC modeling should be tightly coupled with targeted experimen-
tation. Nevertheless, we believe that WC modeling currently can be most cost-effectively advanced
by leveraging the extensive array of public data. To make this public data usable for modeling,
researchers are developing automated methods for extracting data from publications [29], building
central public repositories [30], and creating tools for programmatically accessing repositories [31].
Pathway/genome database (PGDB) tools such as Pathway Tools [32] are well-suited to organizing
this data because they support structured representations of metabolites, DNA, RNA, proteins, and
their interactions. However, they provide limited support for non-metabolic pathways and quanti-
tative data. To overcome these limitations, we developed the WholeCellKB tool to organize data
for WC modeling [33].
Scalable model design
Several new tools can help researchers develop large models. For example, the Cell Collective
facilitates collaborative model design [34], MetaFlux facilitates the design of constraint-based models
from PGDBs [35], PySB facilitates programmatic model construction [36], SEEK facilitates model
design from data tables [37], and Virtual Cell facilitates model design from KEGG and SABIO-RK
[38].
Model languages
Researchers have developed several languages for representing biochemical models. SBML can rep-
resent several types of models including flux balance analysis models, deterministic dynamical mod-
els, and stochastic dynamical models [39]. Rule-based languages such as BioNetGen can efficiently
describe the combinatorial complexity of protein-protein interactions [40].
Simulation
Numerous tools can simulate biomodels. For example, COPASI [41] and Virtual Cell [38] support
deterministic, stochastic, hybrid deterministic/stochastic, network-free, and spatial simulation; CO-
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BRApy supports constraint-based simulation [42]; and E-Cell supports multi-algorithmic simulation
[43].
Calibration
New tools such as saCeSS [44] support distributed calibration of large biochemical models. In
addition, aerospace and mechanical engineers have developed methods for using reduced surrogate
models to efficiently calibrate large models [45].
Verification
Researchers have begun to adapt formal model checking techniques to biomodeling. For example,
BioLab [46] and PRISM [47] can verify BioNetGen-encoded and SBML-encoded models, respec-
tively.
Simulation results analysis
Tools such as COPASI [41] and Virtual Cell [38] can visualize simulation results. We have developed
the WholeCellSimDB [48] simulation results database to help researchers organize, search, and share
WC simulation results. We have also developed the WholeCellViz [49] simulation results dashboard
to help researchers visualize WC simulation results in their biological context.
Technological challenges
Beyond these emerging tools, several technological advances are needed to enable WC models. Here,
we summarize the most critically needed technologies.
Experimental measurement
While substantial data about cellular populations already exists, additional data would enable bet-
ter models. In particular, we need metabolome-wide and proteome-wide measurement technologies
that can quantitate the dynamics and single-cell variation of each metabolite and protein. Addi-
tionally, we need technologies that can measure kinetic parameters at the interactome scale and
technologies that can measure cellular phenotypes across multiple genetic and environmental condi-
tions. Furthermore, to enable WC models of a broad range of organisms, we also need technologies
that can measure non-model organisms, including small, slow-growing, motile, and unculturable
organisms.
Prediction tools
While existing tools can predict many properties of metabolites, DNA, RNA, and proteins, ad-
ditional tools are needed to accurately predict the molecular effects of insertions, deletions, and
structural variants. Such tools would help WC models design microbial genomes and predict the
phenotypes of individual patients.
Data aggregation
As described above, extensive data is now available for WC modeling. However, this data is scat-
tered across many repositories and publications; spans a wide range of data types, organisms, and
environments; is described using inconsistent identifiers and units; and often is not annotated or
normalized. To make this data more usable for modeling, we are developing a framework for aggre-
gating data from repositories; merging data from multiple species, environmental conditions, and
experimental procedures; standardizing data to common units; and identifying the most relevant
data for a model.
Scalable, data-driven model design
To scale WC modeling, we need tools for collaboratively building large models directly from exper-
imental data, recording how data is used to build models, and identifying gaps and inconsistencies
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in models. As described above, several tools support each of these functions. To accelerate WC
modeling, the field must develop an extensible platform that supports all of these functions at the
scale required for WC modeling.
Rule-based model representation
Several languages can represent individual biological processes, but no existing language supports all
of the biological processes that WC models must represent [50, 51]. To overcome this limitation, we
are developing a rule-based language that can represent each molecular species at multiple levels of
granularity (for example, as a single species, as a set of sites, and as a sequence); the combinatorial
complexity of each molecular species and interaction; composite, multi-algorithmic models; and the
data used to build models.
Scalable multi-algorithmic simulation
Simulating WC models requires a simulator that supports both network-free interpretation of rule-
based model descriptions and multi-algorithmic co-simulation of submodels that are described using
different simulation algorithms. However, no existing simulator supports both network-free and
multi-algorithmic simulation. To scalably simulate WC models, we are using Rete algorithms and
parallel discrete event simulation to develop a parallel, network-free, multi-algorithmic simulator
[9].
Calibration and verification
Scalable tools are needed to calibrate and verify WC models. Although we and others have begun to
explore surrogate strategies for efficiently calibrating and validating WC models [52], further work
is needed to formalize these methods.
Simulation analysis
We and others have developed tools for organizing and visualizing simulation results, but they
provided limited support for large datasets or custom visualizations such as pathway maps. To
visualize WC simulation results, researchers should use distributed database and data processing
technologies to search and reduce simulation results, standard visualization grammars to enable
flexible and custom visualizations, and high-performance visualization toolkits to handle terabyte-
scale simulation results.
Collaboration
Ultimately, achieving WC models will require extensive teamwork. To facilitate collaboration, the
field must develop collaborative model design tools, version control systems for models, standards
for annotating and verifying submodels, and protocols for merging separately developed submodels.
Conclusion
WC models have great potential to advance bioscience, bioengineering, and medicine. However,
significant challenges remain to achieve WC models. To advance WC modeling, we have proposed
how WC models should represent cells and the phenotypes that WC models should predict, and
summarized the best emerging methods and resources. We have also outlined several technological
solutions to the most immediate WC modeling challenges. Specifically, we must develop new tools
for scalably and collaboratively designing, simulating, calibrating, validating and analyzing models.
We must also develop new methods for measuring the dynamics and single-cell variation of the
metabolome and proteome and for measuring kinetic parameters at the interactome scale. Despite
these challenges, we and others are building the first WC models, developing the first WC modeling
tools, and beginning to form a WC modeling community [50, 52]. We anticipate that these efforts
will enable comprehensive models of cells.
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